151 related articles for article (PubMed ID: 18602898)
1. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
Ningaraj NS; Rao M; Black KL
Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
[TBL] [Abstract][Full Text] [Related]
3. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
4. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
[TBL] [Abstract][Full Text] [Related]
5. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
[TBL] [Abstract][Full Text] [Related]
6. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
7. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
Ningaraj NS; Rao MK; Black KL
Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
[TBL] [Abstract][Full Text] [Related]
8. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
9. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
Gu YT; Xue YX; Wei XY; Zhang H; Li Y
Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
[TBL] [Abstract][Full Text] [Related]
10. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Zhang H; Xue YX
Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
[TBL] [Abstract][Full Text] [Related]
12. Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
Gu YT; Xue YX; Zhang H; Li Y; Liang XY
Cell Mol Neurobiol; 2011 May; 31(4):629-34. PubMed ID: 21331626
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
[TBL] [Abstract][Full Text] [Related]
14. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.
Black KL; Yin D; Ong JM; Hu J; Konda BM; Wang X; Ko MK; Bayan JA; Sacapano MR; Espinoza A; Irvin DK; Shu Y
Brain Res; 2008 Sep; 1230():290-302. PubMed ID: 18674521
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
16. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
18. Cerebrovascular vasodilation to extraluminal acidosis occurs via combined activation of ATP-sensitive and Ca2+-activated potassium channels.
Lindauer U; Vogt J; Schuh-Hofer S; Dreier JP; Dirnagl U
J Cereb Blood Flow Metab; 2003 Oct; 23(10):1227-38. PubMed ID: 14526233
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure.
Barnett FH; Scharer-Schuksz M; Wood M; Yu X; Wagner TE; Friedlander M
Gene Ther; 2004 Aug; 11(16):1283-9. PubMed ID: 15164099
[TBL] [Abstract][Full Text] [Related]
20. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues.
Ploug KB; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2010 Jul; 637(1-3):109-17. PubMed ID: 20361954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
